John Neis, Director at Cellectar Biosciences, Inc. (CLRB), bought 268,711 shares at $3.75 ($1.0M) on 2014-08-20, disclosed to the SEC on 2014-08-22.
Open-market purchase of $1.0M CLRB by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.75 | 130,000 | $488K | 48.4% |
| 2 | $3.75 | 138,711 | $520K | 51.6% |
| Total | $3.75 avg | 268,711 | $1.0M | 100% |
| Filing → |
| CLRB | BUY | 2016-11-30 | $993K | — | Filing → |
| CLRB | BUY | 2016-04-21 | $995K | — | Filing → |
| TTPY | SELL | 2007-10-18 | $14.1M | — | Filing → |